Limited macular translocation for neovascular maculopathy.
Subfoveal choroidal neovascularization presents one of the most difficult challenges to vision. No treatment option has yet solved the problem of subretinal hemorrhage and fibrovascular scarring causing permanent photoreceptor degeneration and loss. Limited macular translocation provides a surgical approach to this challenge by moving the fovea onto an adjacent area of relatively normal subretinal space and pigment epithelium in a selected group of patients. The choroidal neovascularization, thus, becomes extrafoveal or juxtafoveal and can be treated with focal laser photocoagulation. This article describes the current technique of limited macular translocation and reviews early results. The procedure offers selected patients a chance to retain useful central vision. About 40% of patients at 6 months are able to read and drive (visual acuity >20/100). Complications including retinal detachment, hemorrhage, and macular folds have decreased with experience. Limited macular translocation is a promising approach to neovascular maculopathy, but needs ongoing careful evaluation.
Haller
J A
JA
Wilmer Ophthalmological Institute, Johns Hopkins University, Baltimore, MD 21287, USA. jhaller@jhmi.edu
Hartranft
C D
CD
Fujii
G Y
GY
Pieramici
D
D
Humayun
M S
MS
de Juan
E
E
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002829:Choroid / Q000473:pathology; D020256:Choroidal Neovascularization / Q000175:diagnosis / Q000601:surgery*; D005451:Fluorescein Angiography; D005654:Fundus Oculi; D006801:Humans; D008266:Macula Lutea / Q000637:transplantation*; D008875:Middle Aged; D011183:Postoperative Complications; D011379:Prognosis; D012160:Retina / Q000473:pathology; D012189:Retrospective Studies; D014792:Visual Acuity